Injective vs Kaspa — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while Kaspa trades at Rp522.09 (market cap Rp14,4T, Rp182,85M 24h volume). The key difference: Kaspa is the larger of the two by market cap, and Kaspa's supply is capped (27,6B / 28,7B KAS (97%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Kaspa for 39 Days on average.
| INJ | KAS | |
|---|---|---|
Market Cap | Rp9,18T | Rp14,4T |
Volume (24h) | Rp1,72T | Rp182,85M |
Circulating Supply | 100M INJ | 27,6B / 28,7B KAS (97%) |
Typical Hold Time | 36 Days | 39 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Kaspa is currently trading at Rp523.6 with a bearish technical outlook, showing strong selling pressure across moving averages. The token trades near resistance at Rp525 with support at Rp517. With 97% of the maximum 28.7M KAS supply in circulation and an average hold time of 39 days, the market shows moderate distribution. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with technical indicators favoring sellers. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and limited fundamental catalysts. Investors should monitor volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Kaspa is a fast and scalable Layer-1 cryptocurrency built on a proof-of-work model, powered by the GHOSTDAG protocol. This protocol allows multiple blocks to coexist in a blockDAG structure. Kaspa can process 10 blocks per second, with plans to scale to 100 BPS, providing near-instant confirmation times. Designed for accessibility and decentralization, Kaspa runs smoothly on standard personal computers and supports future Layer-2 solutions for scalable and secure applications.
Read more on KAS →